Glutathione Injections: Skin Claims, Doses and Trade-offs
Skin appearance · energy · wellness drips
People seek glutathione injections hoping for brighter-looking skin, more energy or ‘detox’ support. The body's antioxidant system explains the interest, but it does not tell you whether a drip will deliver those results.
Oral, IV and precursor products answer different questions. An oral skin study cannot prove an injection works better, and a blood-level rise does not establish a lasting benefit.
Three options people often confuse
- Oral glutathione
- The molecule, swallowed Some human studies measured body stores or skin changes.
- IV glutathione
- The molecule, infused A rise in blood levels does not establish lasting skin or energy benefits.
- NAC
- A different molecule A precursor used to help make glutathione, with its own uses and evidence.
Reported amounts and treatment courses
Dr. Suzanne Trott’s clinic describes the following practice, rechecked October 12, 2026. This is one clinic’s published schedule, not an approved cosmetic regimen or proof that maintenance treatment is necessary.
600–1,200 mg
Per IV session
Amount given at a visit, not simply the amount printed on a vial.
6–8 weeks
Weekly visits
Then monthly in this clinic example; a reported schedule, not a demonstrated cosmetic requirement.
IV, muscle and under-skin injections are different routes. Matching their milligrams does not establish equivalent exposure or results.
An oral trial used 250 or 1,000 mg daily for six months and measured glutathione stores. Those study amounts are not a conversion into injectable doses.
What glutathione is
Glutathione is a tripeptide made from glutamate, cysteine and glycine. Its reduced form is commonly called GSH; its oxidized form is GSSG. Cells make and recycle it as part of their antioxidant defenses. Giving extra glutathione raises separate questions about delivery, tissue uptake and whether a person benefits.
Oral, IV and NAC are different questions
A route changes what a study can tell you
| Compare | Oral glutathione studies | Intravenous glutathione |
|---|---|---|
| What has been measured | Body glutathione stores and selected skin measures | Short-term plasma exposure and specific clinical/research outcomes |
| What does not transfer | An oral skin result does not establish injection benefit | A plasma spike does not prove lasting tissue benefit |
| Additional quality requirement | Product identity and formulation still matter | Sterile preparation and endotoxin control are essential |
A randomized six-month study in 54 healthy adults found that oral supplementation increased glutathione stores in several measured compartments. This contradicts a blanket claim that oral glutathione cannot work because it is all destroyed in the gut. It does not demonstrate that healthy users need supplementation or gain a longevity benefit. Primary oral study.
Evidence for skin claims
A small randomized, placebo-controlled study gave reduced or oxidized glutathione orally for 12 weeks and measured pigmentation and other skin features. Some measures improved, while others showed trends rather than clear between-group differences. It was not an IV study and cannot establish a durable injection-based skin-lightening program. Original trial.
When assessing a claim, check route, formulation, comparison group and duration. “Glutathione has a clinical study” is too broad if the offered treatment differs from what was tested.
Pharmacokinetics
A human high-dose IV study reported a mean plasma elimination half-life of about 14 minutes, with considerable variability. The experiment measured plasma glutathione and related metabolites; it did not establish how long a cosmetic or wellness benefit lasts. Aebi et al..
IV administration places the dose directly into the circulation; there is no absorption step to estimate. A subcutaneous or intramuscular model requires separate absorption evidence. A glutathione plot must be read with its route and assumptions visible, not as a timetable for antioxidant protection.
Safety concerns with injectable glutathione
Product quality is not an abstract issue here. FDA investigated reactions after compounded glutathione injections in 2019 and found excessive bacterial endotoxin in tested source material. In 2026, the agency again warned against using dietary-supplement-grade glutathione for injectable products, citing additional quality concerns and recalls. 2019 investigation; 2026 reminder.
A claim of high chemical purity does not demonstrate sterility or acceptable endotoxin levels. Fever, shaking chills, faintness or breathing difficulty after an infusion requires urgent clinical assessment.
Glutathione vs NAC
N-acetylcysteine (NAC) is a different molecule, used as a glutathione precursor. Acetylcysteine products are established antidotes for acetaminophen poisoning; that is not an approval of glutathione injections or a reason to self-treat a suspected overdose. Acetadote label.
The reviewed evidence does not justify recommending NAC to everyone as a cheaper substitute for a wellness drip. First identify a clinical need and an outcome worth treating.
Frequently asked questions
How often do clinics repeat injections? The example above describes weekly visits followed by monthly treatment. That is an attributed clinic schedule, not a clinically established requirement; a brief plasma half-life does not determine repeat timing.
Does “antioxidant” mean anti-aging? No. A biochemical role is not a demonstrated effect on lifespan, symptoms or disease risk.
Can injections treat liver disease? Different liver conditions require different care. Neither an antioxidant explanation nor NAC’s poisoning indication establishes a general glutathione treatment.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.